Explore the frontier of life sciences and healthcare innovation. From breakthrough therapeutics and longevity research to the deep tech investments shaping tomorrow's treatments, discover the trends and breakthroughs redefining global health.
Generative AI has discovered nearly a million antimicrobial peptide candidates in two years. The bottleneck has shifted from discovery to delivery and MIT programmable antibacterials point to a path forward.
DARPA funds two parallel programs for autonomous battlefield medicine: MASH (internal bleeding robotics) and Medical Swarm SBIR (extraction + smart tourniquets). NATO's iMEDCAP demonstrated autonomous casualty evacuation at Vigorous Warrior 2026. Phase 1 awards expected Q4 2026–Q1 2027.
Galux raised $29M Series B for AI-driven de novo antibody design. The platform achieved 31.5% hit rate from 50 designs with cryo-EM validated atomic precision.
Four-minute imaging across 1536-well plates. AI-powered organoid screening is turning drug discovery into an industrial-scale data pipeline.
mbiomics closes €30M Series A for AI/ML-designed microbial consortia — a new class of live biotherapeutic products that could reshape how metabolic and immune diseases are treated.
A security officer in Kyiv gets an alert on a tablet: the air at a checkpoint 300 metres away just tested positive for a chemical agent. No one had to go near it. The detector, a protein-engineered biosensor the size of a deck of cards mounted on a quadcopter,
NIH awards Locus Biosciences $3.3M for Phase 1b trial of AI-designed bacteriophage therapy against antibiotic-resistant Pseudomonas aeruginosa hospital-acquired pneumonia.
The human brain runs on 20 watts. A supercomputer that matches its processing capacity needs at least 10 megawatts — six orders of magnitude of energy difference. That gap is not an engineering inconvenience. It is a physical argument that the dominant computing model of the last fifty years may not